Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia

Noa Krugliak Cleveland, Jacob E. Ollech, Ruben J. Colman, Dylan Rodriquez, Ayal Hirsch, Russell D. Cohen, Stephen B. Hanauer, John Hart, Roger Hurst, David T. Rubin*

*Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

15 Scopus citations


The historical approach to neoplasia in the setting of chronic colitis was to perform a total proctocolectomy. Recent consensus and society guidelines1–3 suggest that when dysplastic lesions can be removed endoscopically, continued surveillance is appropriate. This is based on improvements in optical technologies and the low risk of metachronous colorectal carcinoma in these patients.4–6 We hypothesized that if a lesion was completely removed surgically and followed up endoscopically, metachronous colorectal carcinoma would be a rare occurrence. Thus, segmental resection may be offered as a definitive surgery in patients with chronic colitis and localized colorectal neoplasia in whom endoscopic resection is not feasible. Retention of the distal colon/rectum is expected to result in an overall improved quality of life compared with permanent ileostomy or an ileoanal J-pouch. Here, we report our experience and follow-up evaluation of segmental resections for preoperative neoplasia in patients with Crohn's disease (CD) or ulcerative colitis (UC).

Original languageEnglish (US)
Pages (from-to)205-206
Number of pages2
JournalClinical Gastroenterology and Hepatology
Issue number1
StatePublished - Jan 2019

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology


Dive into the research topics of 'Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia'. Together they form a unique fingerprint.

Cite this